EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

MicroRNA in the Diagnosis and Treatment of Doxorubicin-Induced Cardiotoxicity

Ziyu Kuang iD, Jingyuan Wu, Ying Tan, Guanghui Zhu, Jie Li, Min Wu

Biomolecules · 2023

DOI: 10.3390/biom13030568 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, 2023. Verfasst von Ziyu Kuang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Oncology Department, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China. Hauptthemen laut MEDLINE: MicroRNAs, Neoplasms. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 220 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Doxorubicin (DOX), a broad-spectrum chemotherapy drug, is widely applied to the treatment of cancer; however, DOX-induced cardiotoxicity (DIC) limits its clinical therapeutic utility. However, it is difficult to monitor and detect DIC at an early stage using conventional detection methods. Thus, sensitive, accurate, and specific methods of diagnosis and treatment are important in clinical practice. MicroRNAs (miRNAs) belong to non-coding RNAs (ncRNAs) and are stable and easy to detect. Moreover, miRNAs are expected to become biomarkers and therapeutic targets for DIC; thus, there are currently many studies focusing on the role of miRNAs in DIC. In this review, we list the prominent studies on the diagnosis and treatment of miRNAs in DIC, explore the feasibility and difficulties of using miRNAs as diagnostic biomarkers and therapeutic targets, and provide recommendations for future research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsNeoplasmsHumansCardiotoxicityDoxorubicinBiomarkersMyocytes, Cardiac

Stichwörter der Autor:innen

biomarkerdoxorubicin-induced cardiotoxicitymicroRNAtherapeutic target

Substanzen

MicroRNAsDoxorubicinBiomarkers

Autor:innen und Institutionen

  • Oncology Department, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China.
  • Graduate School, Beijing University of Chinese Medicine, Beijing 100029, China.
  • Cardiovascular Department, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China.

ORCID-Profile: Ziyu Kuang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Kuang, Z., Wu, J., Tan, Y., Zhu, G., Li, J., & Wu, M. (2023). MicroRNA in the Diagnosis and Treatment of Doxorubicin-Induced Cardiotoxicity. Biomolecules. https://doi.org/10.3390/biom13030568

Vancouver

Kuang Z, Wu J, Tan Y, Zhu G, Li J, Wu M. MicroRNA in the Diagnosis and Treatment of Doxorubicin-Induced Cardiotoxicity. Biomolecules. 2023. doi:10.3390/biom13030568

BibTeX
@article{Kuang2023,
  author = {Kuang, Ziyu and Wu, Jingyuan and Tan, Ying and Zhu, Guanghui and Li, Jie and Wu, Min},
  title = {MicroRNA in the Diagnosis and Treatment of Doxorubicin-Induced Cardiotoxicity},
  journal = {Biomolecules},
  year = {2023},
  doi = {10.3390/biom13030568}
}
Kostenlos starten →